Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA, et al.
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Donohue JF, et al.
The safety and efficacy of arformoterol and formoterol in COPD.
Hanania NA, et al.
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials.
Hanrahan JP, et al.
back
are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd.
